EUCTR2009-013786-25-GB进行中（未招募）不适用
Comparison of the effect of Etoricoxib and Diclofenac on early morning activity in RA.
orthumbria Healthcare NHS Foundation Trust0 个研究点目标入组 20 人开始时间: 2010年3月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male and female subjects aged 18 years and over.
- •Subjects who are NSAID tolerant.
- •Subjects with a clinical diagnosis of rheumatoid arthritis.
- •Subjects who are willing to complete QOL questionnaires.
- •Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Co-occurrence of other disabling conditions in addition to rheumatoid arthritis likely to warrant the persistent use of escape analgesia.
- •Subjects who have received an intra-articular or muscular steroid injection within 3 months of study entry or in whom such treatment is planned within the study period.
- •Subjects scheduled for elective surgery of the disease site or any other elective major surgery which would fall within the study period.
- •Severe respiratory impairment.
- •Clinically significant hepatic or renal dysfunction, subjects whose LFTs and serum creatinine is outside normal recognized limits.
- •Subjects with convulsive disorders, head injury, shock, reduced level of consciousness of uncertain origin, intracranial lesions or increased intracranial pressure.
- •Subjects with a known allergy or hypersensitivity to NSAIDs.
- •Subjects with unstable gastro-intestinal complications or disease.
- •Subjects who currently abuse alcohol or drugs, or have a recent history of alcohol or drug abuse, or who in the Investigator’s opinion, have previously demonstrated drug-seeking behaviour.
- •Subjects who are currently participating in another clinical research study involving a new chemical entity or who have participated in a clinical study within the previous 30 days.
研究者
相似试验
进行中（未招募）
1 期
A randomized study comparing etoricoxib and diclofenac sodium in post hallux valgus surgery paiPostoperative painMedDRA version: 12.1Level: PTClassification code 10056350Term: Pain managementEUCTR2010-020547-13-SEFoot and Ankle Surgical center200
撤回
4 期
Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)Rheumatoid ArthritisNCT01067430Northumbria Healthcare NHS Foundation Trust
已完成
3 期
evaluation of two doses of Etoricoxib (90mg and 120mg) as pre-operative preemptive analgesic for postoperative pain relief in mandibular fracture surgeryCTRI/2017/08/009272All India Institute Of Medical Sciences New Delhi60
已完成
不适用
A comparison of the effects of rofecoxib and diclofenac on the PFA-100, a laboratory based indicator of platelet function, in a post-operative neurosurgical populatioPlatelet dysfunctionHaematological DisordersPurpura and other haemorrhagic conditionsISRCTN73370863Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)30
招募中
4 期
The effectiveness of etoricoxib compare with acetaminophen as analgesia for post-operative pain relief in lumbar laminectomypost-operative pain after lumbar laminactomylaminectomyoperative painmorphineEtoricoxibTCTR20181223001Invitation research grant, Faculty of Medicine KK40